Imperial College London
Professor Robert Wilkinson

ProfessorRobertWilkinson

Faculty of Medicine, Department of Infectious Disease

Professor in Infectious Diseases
 
 
 
//

Contact

 

r.j.wilkinson Website

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Fendler:2022:10.1016/j.ccell.2022.03.010,
author = {Fendler, A and Shepherd, STC and Au, L and Wilkinson, KA and Wu, M and Schmitt, AM and Tippu, Z and Farag, S and Rogiers, A and Harvey, R and Carlyle, E and Edmonds, K and Del, Rosario L and Lingard, K and Mangwende, M and Holt, L and Ahmod, H and Korteweg, J and Foley, T and Barber, T and Emslie-Henry, A and Caulfield-Lynch, N and Byrne, F and Shum, B and Gerard, CL and Deng, D and Kjaer, S and Song, O-R and Queval, C and Kavanagh, C and Wall, EC and Carr, EJ and Namjou, S and Caidan, S and Gavrielides, M and MacRae, JI and Kelly, G and Peat, K and Kelly, D and Murra, A and Kelly, K and O'Flaherty, M and Shea, RL and Gardner, G and Murray, D and Popat, S and Yousaf, N and Jhanji, S and Van, As N and Young, K and Furness, AJS and Pickering, L and Beale, R and Swanton, C and Crick, COVID19 consortium and Gandhi, S and Gamblin, S and Bauer, DLV and Kassiotis, G and Howell, M and Nicholson, E and Walker, S and Wilkinson, RJ and Larkin, J and Turajlic, S and CAPTURE, consortium},
doi = {10.1016/j.ccell.2022.03.010},
journal = {Cancer Cell},
pages = {438--438},
title = {Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.},
url = {http://dx.doi.org/10.1016/j.ccell.2022.03.010},
volume = {40},
year = {2022}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - In this report from the CAPTURE study (NCT03226886), we demonstrate that a third dose of COVID-19 vaccine boosts neutralizing antibody (NAb) and cellular responses in patients with cancer, including those that had undetectable NAb titers (NAbT) following two vaccine doses or for whom NAbT waned. We have noted that one key member of the CAPTURE consortium—Sanjay Popat—was inadvertently not included in the author list. We now include him as a co-author. There are no additional changes to the declaration of interests statement, since Dr. Popat declares no competing conflict of interest. This author list change is now reflected in the online version of this letter.
AU  - Fendler,A
AU  - Shepherd,STC
AU  - Au,L
AU  - Wilkinson,KA
AU  - Wu,M
AU  - Schmitt,AM
AU  - Tippu,Z
AU  - Farag,S
AU  - Rogiers,A
AU  - Harvey,R
AU  - Carlyle,E
AU  - Edmonds,K
AU  - Del,Rosario L
AU  - Lingard,K
AU  - Mangwende,M
AU  - Holt,L
AU  - Ahmod,H
AU  - Korteweg,J
AU  - Foley,T
AU  - Barber,T
AU  - Emslie-Henry,A
AU  - Caulfield-Lynch,N
AU  - Byrne,F
AU  - Shum,B
AU  - Gerard,CL
AU  - Deng,D
AU  - Kjaer,S
AU  - Song,O-R
AU  - Queval,C
AU  - Kavanagh,C
AU  - Wall,EC
AU  - Carr,EJ
AU  - Namjou,S
AU  - Caidan,S
AU  - Gavrielides,M
AU  - MacRae,JI
AU  - Kelly,G
AU  - Peat,K
AU  - Kelly,D
AU  - Murra,A
AU  - Kelly,K
AU  - O'Flaherty,M
AU  - Shea,RL
AU  - Gardner,G
AU  - Murray,D
AU  - Popat,S
AU  - Yousaf,N
AU  - Jhanji,S
AU  - Van,As N
AU  - Young,K
AU  - Furness,AJS
AU  - Pickering,L
AU  - Beale,R
AU  - Swanton,C
AU  - Crick,COVID19 consortium
AU  - Gandhi,S
AU  - Gamblin,S
AU  - Bauer,DLV
AU  - Kassiotis,G
AU  - Howell,M
AU  - Nicholson,E
AU  - Walker,S
AU  - Wilkinson,RJ
AU  - Larkin,J
AU  - Turajlic,S
AU  - CAPTURE,consortium
DO  - 10.1016/j.ccell.2022.03.010
EP  - 438
PY  - 2022///
SN  - 1535-6108
SP  - 438
TI  - Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
T2  - Cancer Cell
UR  - http://dx.doi.org/10.1016/j.ccell.2022.03.010
UR  - https://www.ncbi.nlm.nih.gov/pubmed/35413273
UR  - https://www.cell.com/cancer-cell/fulltext/S1535-6108(22)00125-8#relatedArticles
UR  - http://hdl.handle.net/10044/1/96677
VL  - 40
ER  -
Download